retatrutide triumph weight loss results clinical trial 🚨 BREAKING: Shows “Bariatric-Level” in Phase 3 New Phase A Study of Retatrutide (LY3437943)

Kosower et al [11] had previously reported that monobromobimane (a derivative of 1,5-diazobicyclo[3,3,0] actadiendiones) and non fluorescent compound with an electrophilic site, slowly reacted with glutathione to form fluorescent glutathione conjugate and that the reaction might be catalysed by glutathione transferase

This is why injections are often discussed when the target is not mainly the gut

Or are the benefits of weight loss independent and do they require ongoing therapy with GLP-1 medicines

van den Hoogenhof MMG, Beqqali A, Amin AS, van dM I, Aufiero S, Khan MAF, Schumacher CA, Jansweijer JA, van Spaendonck-Zwarts KY, Remme CA, Backs J, Verkerk AO, Baartscheer A, Pinto YM, Creemers EE (2018) RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling